VIM and cancer: This resulted in poorly differentiated, more mesenchymal tumours containing predominantly vimentin+ (Vim+) mesenchymal-like PDAC cells, less epithelial-like CK19+ glandular PDAC cells and a significantly higher number of CK19+Vim+ hybrid EMT cancer cells.